Private Equity
NewView Capital Fund IV arrives in the market as venture secondaries are heating up, driven by overallocated LPs pressing GPs to expand distributions as a way to replenish capital stocks
3 min read · 09 December 2025
The population of zombie funds is huge, and likely growing. Detecting early warning signs is the key to value preservation.
6 min read · 05 December 2025
The sheer volume of management company, fund and portfolio-level data involved in GP stakes investing means the asset class is ripe for an AI revolution.
5 min read · 01 December 2025
Of the $60bn of third quarter deal volume, GP-leds represented about 52%, according to PJT Partners’ Q3 2025 Secondary Market Insight report.
2 min read · 26 November 2025
Haarmann tells us about his fantasy job as a pro hockey player, his love of ‘powder days,’ and why Omakase is a thrilling dining experience.
4 min read · 24 November 2025
Research provided to Buyouts by TREO indicates the global volume of AUM of tail-end funds, or TEFs, hit $829bn in 2024, up 24% from 2023.
3 min read · 21 November 2025
In a rebounding biotech market, royalty finance can play a far more strategic role, provided it’s executed with disciplined underwriting, smart structuring and a genuine partnership with innovators, according to Ryan Murr, a partner at Gibson, Dunn & Crutcher.
5 min read · 19 November 2025
Trilantic’s deal is viewed by many in the secondaries market as a potential precedent setting transaction that could serve as a model for other mid-market firms facing fundraising challenges.
3 min read · 19 November 2025
The investor in small- to mid-sized businesses outdid its last fundraise target by more than a third.
1 min read · 17 November 2025
Many managers will continue to raise continuation vehicles, but others are taking more drastic action to escape the inertia of a stalled market.
4 min read · 14 November 2025
